Drug profile · INN
lercanidipine + enalapril
ZAN-EXTRA 10/20
lercanidipine + enalapril (ZAN-EXTRA 10/20) is an FDA-listed pharmaceutical active ingredient. Associated with Viatris Pharmaceuticals Co.,.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — lercanidipine + enalapril
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
lercanidipine + enalapril (ZAN-EXTRA 10/20) is an FDA-listed pharmaceutical active ingredient. Associated with Viatris Pharmaceuticals Co.,.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is lercanidipine + enalapril?
lercanidipine + enalapril (ZAN-EXTRA 10/20) is an FDA-listed pharmaceutical active ingredient. Associated with Viatris Pharmaceuticals Co.,.
What is the brand name for lercanidipine + enalapril?
ZAN-EXTRA 10/20 is a marketed brand name for lercanidipine + enalapril. Check FDA Drugs@FDA for the current US label holder and prescribing information.